New Standards of Care in the Management of Prostate CancerBySurabhi Dangi-Garimella, PhDFebruary 16th 2015
Payers Evaluate the Clinical Utility of Diagnostic TestsBySurabhi Dangi-Garimella, PhDFebruary 16th 2015
The Use and Implementation of Standardized Treatment PathwaysBySejal Saraiya, PharmDFebruary 16th 2015
Arguments Taking Shape For and Against FDA Regulation of Diagnostic TestsByMary K. CaffreyFebruary 16th 2015
Study Results Support Early Treatment With Abiraterone in Prostate CancerBySurabhi Dangi-Garimella, PhDFebruary 16th 2015
Patient Cost-Sharing in Oncology and the Patient Access Network FoundationByDan KleinFebruary 16th 2015
Immuno-Oncology Poised to Revolutionize Patient CareByLee S. Schwartzberg, MD, FACPFebruary 15th 2015
Money Well Spent: the Need for Federal Funding in Cancer ResearchByJohn R. Seffrin, PhDFebruary 15th 2015
